Total Payments
$50,226
2024 Payments
$1,860
Companies
20
Transactions
173
Medicare Patients
2,453
Medicare Billing
$643,473
Payment Breakdown by Category
Other$33,817 (67.3%)
Consulting$7,425 (14.8%)
Food & Beverage$4,654 (9.3%)
Travel$4,297 (8.6%)
Education$32.69 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $29,820 | 29 | 59.4% |
| Consulting Fee | $7,425 | 3 | 14.8% |
| Food and Beverage | $4,654 | 119 | 9.3% |
| Travel and Lodging | $4,297 | 14 | 8.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,997 | 4 | 8.0% |
| Education | $32.69 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $34,700 | 80 | $0 (2023) |
| Outset Medical Inc | $10,498 | 6 | $0 (2024) |
| Vifor Pharma, Inc. | $2,828 | 9 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $600.46 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $318.19 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $243.97 | 13 | $0 (2024) |
| Amgen Inc. | $185.89 | 7 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $121.71 | 1 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $113.51 | 4 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $86.23 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 18 | Outset Medical Inc ($1,400) |
| 2023 | $8,371 | 46 | Outset Medical Inc ($6,573) |
| 2022 | $15,631 | 53 | Horizon Therapeutics plc ($12,301) |
| 2021 | $8,021 | 24 | Horizon Therapeutics plc ($4,960) |
| 2020 | $5,819 | 13 | Horizon Therapeutics plc ($5,781) |
| 2019 | $10,418 | 15 | Horizon Therapeutics plc ($10,418) |
| 2018 | $80.83 | 3 | BAXTER HEALTHCARE ($80.83) |
| 2017 | $24.44 | 1 | Keryx Biopharmaceuticals, Inc. ($24.44) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardio-renal | ||||||
| 10/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $78.84 | General |
| Category: General - DBS_NMD | ||||||
| 10/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Nephrology | ||||||
| 08/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Nephrology | ||||||
| 06/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.85 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Nephrology | ||||||
| 03/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Cardio-renal | ||||||
| 03/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/07/2024 | Outset Medical Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| 03/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Nephrology | ||||||
| 02/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: Nephrology | ||||||
| 01/12/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/15/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Nephrology | ||||||
| 12/14/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 12/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Cardio-renal | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: KRYSTEXXA | ||||||
| 11/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Education | In-kind items and services | $5.58 | General |
| Category: KRYSTEXXA | ||||||
| 11/03/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 720 | 1,816 | $398,636 | $153,463 |
| 2022 | 14 | 710 | 1,767 | $327,006 | $153,275 |
| 2021 | 7 | 445 | 1,432 | $305,824 | $160,676 |
| 2020 | 8 | 578 | 2,025 | $362,518 | $176,059 |
Total Patients
2,453
Total Services
7,040
Medicare Billing
$643,473
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 210 | 889 | $143,030 | $58,932 | 41.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 23 | 123 | $89,280 | $36,429 | 40.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 138 | 149 | $54,210 | $21,650 | 39.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 74 | 214 | $30,660 | $12,776 | 41.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 37 | $22,895 | $9,174 | 40.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 35 | 94 | $16,920 | $6,402 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 25 | $8,021 | $2,527 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,660 | $2,145 | 37.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 22 | 28 | $8,960 | $1,133 | 12.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 25 | 33 | $6,270 | $957.33 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 48 | $1,200 | $400.46 | 33.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 21 | 32 | $6,400 | $265.28 | 4.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 26 | 37 | $1,332 | $234.58 | 17.6% |
| 84100 | Phosphate level | Office | 2023 | 27 | 38 | $988.00 | $176.70 | 17.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 16 | 20 | $1,540 | $113.20 | 7.4% |
| 82540 | Creatine measurement | Office | 2023 | 16 | 20 | $640.00 | $91.00 | 14.2% |
| 84550 | Uric acid level, blood | Office | 2023 | 12 | 13 | $630.00 | $57.59 | 9.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 217 | 831 | $99,720 | $49,806 | 49.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 18 | 132 | $77,220 | $39,956 | 51.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 148 | 162 | $53,460 | $26,802 | 50.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 96 | 262 | $31,440 | $16,006 | 50.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 42 | $20,370 | $10,720 | 52.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 52 | 127 | $23,440 | $7,575 | 32.3% |
| 82306 | Vitamin d-3 level | Office | 2022 | 24 | 30 | $5,700 | $878.20 | 15.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 15 | 16 | $5,120 | $653.03 | 12.8% |
About Dr. Brian Lee, MD
Dr. Brian Lee, MD is a Nephrology healthcare provider based in Lynwood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558457556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Lee, MD has received a total of $50,226 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 173 transactions from 20 companies. The most common payment nature is "Honoraria" ($29,820).
As a Medicare-enrolled provider, Lee has provided services to 2,453 Medicare beneficiaries, totaling 7,040 services with total Medicare billing of $643,473. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Lynwood, CA
- Active Since 10/05/2006
- Last Updated 06/21/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558457556
Products in Payments
- KRYSTEXXA (Biological) $34,691
- Kerendia (Drug) $429.00
- XARELTO (Drug) $318.19
- Veltassa (Drug) $288.69
- Parsabiv (Drug) $168.77
- Auryxia (Drug) $137.95
- FARXIGA (Drug) $128.95
- LUPKYNIS (Drug) $121.71
- TARPEYO (Drug) $86.23
- IBSRELA (Drug) $85.00
- ACTHAR (Biological) $81.89
- LOKELMA (Drug) $81.21
- Renal - Non Product Related (Biological) $80.83
- JYNARQUE (Drug) $52.36
- Velphoro (Drug) $43.09
- BENLYSTA (Biological) $41.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lynwood
Dr. Ramon Guadiz, M.d, M.D
Nephrology — Payments: $13,677
Nephrology $13,677
Sita Yanamadala, M.d, M.D
Nephrology — Payments: $5,267
Nephrology $5,267
Rodrigo Rocha, M.d, M.D
Nephrology — Payments: $3,287
Nephrology $3,287
Stephen Lui, M.d, M.D
Nephrology — Payments: $143.66
Nephrology $143.66
Samia Khwaja, M.d, M.D
Nephrology — Payments: $72.15
Nephrology $72.15
Andy Hong, Md, MD
Nephrology
Nephrology